US2010098635A1PendingUtilityA1
Modular antigen transporter molecules (mat molecules) for modulating immune reactions, associated constructs, methods and uses
Est. expiryOct 11, 2022(expired)· nominal 20-yr term from priority
A61P 37/00A61P 37/04A61P 37/08A61P 37/06A61P 39/00C12N 2810/40C12N 15/62A61P 35/00C07K 2319/10A61P 29/00A61P 31/00C07K 14/38C07K 2319/40C12N 2310/111A61K 39/00
44
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
It is therefore the object of the invention to provide means for supplying any of a wide variety of antigens in a sufficiently targeted manner to their processing site that even better therapeutic and diagnostic use thereof is possible.
Claims
exact text as granted — not AI-modified1 - 38 . (canceled)
39 . A method for treating or diagnosing a malignant disease, an allergy, or an infectious disease in an individual, comprising the step of providing said individual with a modular antigen transport (MAT)-molecule or a composition comprising a MAT-molecule, wherein said MAT molecule comprises
at least one translocation module which brings about transport of the MAT molecule from the extracellular space into an interior of a cell; at least one targeting module which brings about transport of the MAT molecule intracellularly to organelles which are involved in processing of antigens or loading of major histocompatibility complex (MHC) molecules with antigens, and at least one antigen, wherein provision of the MAT molecule or the composition comprising the MAT molecule produces an immune response in the individual.
40 . The method of claim 39 , wherein the method is a method for treating or diagnosing an allergy in the individual.
41 . The method of claim 39 , wherein the method is a method for treating or diagnosing an infectious disease in the individual.
42 . A method for treatment of a disease in an individual comprising the step of injecting modular antigen transport (MAT)-molecules or a composition comprising MAT-molecules into a lymph node of said individual.
43 . A method of vaccinating an individual to prevent or ameliorate a disease or condition in the individual, comprising the step of
providing to the individual a modular antigen transport (MAT)-molecule or a composition comprising a MAT-molecule, wherein the MAT molecule comprises at least one translocation module which brings about transport of the MAT molecule from an extracellular space into an interior of a cell; at least one targeting module which brings about transport of the MAT molecule intracellularly to organelles which are involved in processing of antigens or loading of major histocompatibility complex (MHC) molecules with antigens; and at least one antigen; wherein provision of the MAT-molecule or the composition comprising the MAT-molecule produces an immune response in the individual.
44 . The method of claim 43 , wherein the immune response is a protective humoral response.Join the waitlist — get patent alerts
Track US2010098635A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.